Averitas Pharma, Inc.
Averitas Pharma, Inc.
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy | Diabetes Complications, Diabetic Neuralgia, diabetes mellitus, diabetic neuropathy, endocrine system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Active, not recruiting | Not stated | 2026-07-13 | NCT06495424 | |
| Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study | Peripheral Neuropathy Due to Chemotherapy | Recruiting | Early phase 1 | 2026-06-26 | NCT06744816 | |
| Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy | Back Pain, Low Back Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Enrolling by invitation | Not stated | 2026-03-20 | NCT06540456 |